that scientists contacted him about the drug, which is designed to designed to specifically target cancer cells.
“It can’t see healthy cells,” says Taylor, who had his first treatment about six weeks ago. “It kills stage four cancer in your bones. And so what it’s effectively done is extend my life for five years.” Lutetium-177 was approved by the U.S. Food and Drug Administration in March 2022. The drug has “proven to significantly improve prostate cancer survival rates and quality of life, as well as extend the time it takes for the disease to progress,” according to theTaylor revealed his cancer diagnosis through a letter read by his bandmates during their induction into the& Roll Hall last November.
Taylor told BBC that he was “massively disappointed” to miss the Rock Hall ceremony, which he referred to as “the biggest night of my life.”Man’s a Wolf to Man
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: DEADLINE - 🏆 109. / 63 Read more »
Source: bbchealth - 🏆 143. / 63 Read more »
Source: RollingStone - 🏆 483. / 51 Read more »
Source: nypost - 🏆 91. / 67 Read more »
Source: TMZ - 🏆 379. / 59 Read more »